Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-15-033757
Filing Date
2015-08-28
Accepted
2015-08-28 13:07:36
Documents
1
Effectiveness Date
2015-08-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12013
  Complete submission text file 0001140361-15-033757.txt   13150
Mailing Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451
Business Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-246643 | Film No.: 151081275
SIC: 2834 Pharmaceutical Preparations